Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91Stefan Rutkowski, André von Bueren, Katja von Hoff, et al.
Bone Marrow Transplantation|January 15, 2014
High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)M Benesch, K Bartelheim, G Fleischhack, et al.
Nature Communications|December 4, 2025
Discovery of an allosteric binding site for anthraquinones at the human P2X4 receptorJessica Nagel, Vigneshwaran Namasivayam, Stephanie Weinhausen, et al.
Lancet (London, England)|September 5, 2009
Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 studyKarin C Straathof, Kanchan Rao, Matthias Eyrich, et al.
Bone Marrow Transplantation|October 23, 2012
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experienceR Beier, A Schulz, M Hönig, et al.
Klinische Padiatrie|May 19, 2015
Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemiaM M Chao, W Ebell, P Bader, et al.
Journal of Neuro-Oncology|March 5, 2019
Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical studyG Fleischhack, M Massimino, M Warmuth-Metz, et al.
Plos One|January 24, 2020
Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatmentHolger Ottensmeier, Paul G Schlegel, Matthias Eyrich, et al.
British Journal of Pharmacology|December 28, 2019
Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitorsMarkus Kuschak, Vigneshwaran Namasivayam, Muhammad Rafehi, et al.
BMC Cancer|February 18, 2016
MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-propertiesSebastian Dietl, Stefanie Schwinn, Susanne Dietl, et al.
Pageof 22